Radformation
Radformation develops software tools that automate and streamline radiation therapy treatment planning and quality assurance workflows for oncology clinics and hospitals, helping medical physicists and dosimetrists improve plan quality, consistency, and efficiency. The company sells its products on a subscription and license basis to cancer centers and radiotherapy providers worldwide.
- Clinical Trial & Research Software
- Revenue
- $35.0M
- Employees
- 170
- Founded
- 2016
- Headquarters
- New York City, United States of America
What 7 Arbolus experts think of Radformation
7 customers have reviewed Radformation so far. The full customer report is in progress and publishes once enough customers have been interviewed in depth.
Who reviewed Radformation
- C-Suite 86% (6)
- Manager 14% (1)
Employer names and spend open once the report publishes.
Tell us when the Radformation report publishes.
We'll email you once the full customer report is ready, with employer names, spend and every written answer. No account needed.
Sentiment
85 Net Promoter Score, from 7 scored reviews- Promoters 6
- Passives 1
- Detractors 0
Written answers and themes publish with the full report.
Renewal intent
Plan to renew 80%Plan to renew, by seniority
- 80% 5 answers
- 9.5/10 Average score from customers who will renew
- 7/10 Average score from undecided customers
More in Data & Analytics and Workplace & Productivity
Other companies in both categories with a customer report.
For people who use Radformation
Do you use Radformation at work?
Share your software review and get matched to paid projects. Arbolus pays you every time a client reads your review.
- 7 customers of Radformation have already contributed
Takes a few minutes. Your identity stays anonymous.